{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:51:44Z","timestamp":1794397904947,"version":"4.9.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>\n                    Parkinson\u2019s disease (PD) is a neurodegenerative condition with several major hallmarks, including loss of\n                    <jats:italic>substantia nigra<\/jats:italic>\n                    neurons, reduction in striatal dopaminergic function, and formation of \u03b1-synuclein-rich Lewy bodies. Mutations in\n                    <jats:italic>SNCA<\/jats:italic>\n                    , encoding for \u03b1-synuclein, are a known cause of familial PD, and the G51D mutation causes a particularly aggressive form of the condition. CRISPR\/Cas9 technology was used to introduce the G51D mutation into the endogenous rat\n                    <jats:italic>SNCA<\/jats:italic>\n                    gene.\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/+<\/jats:sup>\n                    and\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats were born in Mendelian ratios and did not exhibit any severe behavourial defects.\n                    <jats:italic>L<\/jats:italic>\n                    -3,4-dihydroxy-6-\n                    <jats:sup>18<\/jats:sup>\n                    F-fluorophenylalanine (\n                    <jats:sup>18<\/jats:sup>\n                    F-DOPA) positron emission tomography (PET) imaging was used to investigate this novel rat model. Wild-type (WT),\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/+<\/jats:sup>\n                    and\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats were characterized over the course of ageing (5, 11, and 16\u2009months old) using\n                    <jats:sup>18<\/jats:sup>\n                    F-DOPA PET imaging and kinetic modelling. We measured the influx rate constant (\n                    <jats:italic>\n                      K\n                      <jats:sub>i<\/jats:sub>\n                    <\/jats:italic>\n                    ) and effective distribution volume ratio (\n                    <jats:italic>EDVR<\/jats:italic>\n                    ) of\n                    <jats:sup>18<\/jats:sup>\n                    F-DOPA in the striatum relative to the cerebellum in WT,\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/+<\/jats:sup>\n                    and\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats. A significant reduction in\n                    <jats:italic>EDVR<\/jats:italic>\n                    was observed in\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats at 16\u2009months of age indicative of increased dopamine turnover. Furthermore, we observed a significant asymmetry in\n                    <jats:italic>EDVR<\/jats:italic>\n                    between the left and right striatum in aged\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats. The increased and asymmetric dopamine turnover observed in the striatum of aged\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D\/G51D<\/jats:sup>\n                    rats reflects one aspect of prodromal PD, and suggests the presence of compensatory mechanisms.\n                    <jats:italic>SNCA<\/jats:italic>\n                    <jats:sup>G51D<\/jats:sup>\n                    rats represent a novel genetic model of PD, and kinetic modelling of\n                    <jats:sup>18<\/jats:sup>\n                    F-DOPA PET data has identified a highly relevant early disease phenotype.\n                  <\/jats:p>","DOI":"10.3389\/fnins.2023.1095761","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T02:10:15Z","timestamp":1684894215000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["In vivo18F-DOPA PET imaging identifies a dopaminergic deficit in a rat model with a G51D \u03b1-synuclein mutation"],"prefix":"10.3389","volume":"17","author":[{"given":"Victoria","family":"Morley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamjit Singh","family":"Dolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Alcaide-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tashfeen","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lucatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoji","family":"Mashimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana A. S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Kunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation","volume":"128","author":"Adams","year":"2005","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/cne.903050111","article-title":"Species-specific distribution of aromatic L-amino acid decarboxylase in the rodent adrenal gland, cerebellum, and olfactory bulb","volume":"305","author":"Baker","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0301-0082(98)00006-9","article-title":"Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach","volume":"55","author":"Bezard","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1046\/j.1471-4159.1995.64041669.x","article-title":"Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain","volume":"64","author":"Blanchard","year":"1995","journal-title":"J. Neurochem."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2012.05.018","article-title":"The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study","volume":"48","author":"Blesa","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.410280412","article-title":"Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"28","author":"Brooks","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","article-title":"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data","volume":"57","author":"Burn","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2004.02.026","article-title":"Exacerbated synucleinopathy in mice expressing A53T SNCA on a SNCA null background","volume":"26","author":"Cabin","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.expneurol.2012.11.007","article-title":"Expression of human E46K-mutated \u03b1-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment","volume":"240","author":"Cannon","year":"2013","journal-title":"Exp. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mds.27296","article-title":"New developments in genetic rat models of Parkinson's disease","volume":"33","author":"Creed","year":"2018","journal-title":"Mov. Disord."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref200","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1474-4422(06)70549-X","article-title":"The mystery of motor asymmetry in Parkinson\u2019s disease","volume":"5","author":"Djaldetti","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/(SICI)1098-2396(199807)29:3<225::AID-SYN4>3.0.CO;2-8","article-title":"6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys","volume":"29","author":"Doudet","year":"1998","journal-title":"Synapse"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1093\/hmg\/ddl242","article-title":"\u03b2-Synuclein modulates \u03b1-synuclein neurotoxicity by reducing \u03b1-synuclein protein expression","volume":"15","author":"Fan","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.1987.tb05629.x","article-title":"Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate","volume":"48","author":"Firnau","year":"1987","journal-title":"J. Neurochem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/305137a0","article-title":"Dopamine visualized in the basal ganglia of living man","volume":"305","author":"Garnett","year":"1983","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.expneurol.2016.10.009","article-title":"Functional alterations of the dopaminergic and glutamatergic systems in spontaneous \u03b1-synuclein overexpressing rats","volume":"287","author":"Guatteo","year":"2017","journal-title":"Exp. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2967\/jnumed.110.087114","article-title":"Using the NEMA NU 4 PET image quality phantom in multipinhole small-animal SPECT","volume":"52","author":"Harteveld","year":"2011","journal-title":"J. Nucl. Med."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","article-title":"\u03b2-Synuclein inhibits \u03b1-synuclein aggregation: a possible role as an anti-parkinsonian factor","volume":"32","author":"Hashimoto","year":"2001","journal-title":"Neuron"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archneur.1997.00550140025008","article-title":"Functional effects of striatal dysfunction in Parkinson disease","volume":"54","author":"Holthoff-Detto","year":"1997","journal-title":"Arch. Neurol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/brain\/awl332","article-title":"The fate of striatal dopaminergic neurons in Parkinson\u201cs disease and Huntington\u201ds chorea","volume":"130","author":"Huot","year":"2007","journal-title":"Brain"},{"key":"ref24","first-page":"171","article-title":"Strain differences in vulnerability of hippocampal neurons to transient cerebral ischaemia in the rat","volume":"76","author":"Iwasaki","year":"1995","journal-title":"Int. J. Exp. Pathol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","article-title":"\u03b1-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?","volume":"125","author":"Kiely","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.nbd.2015.10.021","article-title":"Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC \u03b1-synuclein transgenic rat model of Parkinson\u2019s disease","volume":"85","author":"Kohl","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0024-3205(78)90538-6","article-title":"Dopamine receptor binding in vivo: the feasibility of autoradiographic studies","volume":"22","author":"Kuhar","year":"1978","journal-title":"Life Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2191-219X-1-25","article-title":"Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats","volume":"1","author":"Kyono","year":"2011","journal-title":"EJNMMI Res."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/987084","article-title":"Effects of human \u03b1-Synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease","volume":"2011","author":"Lelan","year":"2011","journal-title":"Parkinson's Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1-synuclein mutation causes a novel parkinsonian-pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0969-8051(00)00137-2","article-title":"Graphical analysis of PET data applied to reversible and irreversible tracers","volume":"27","author":"Logan","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1002\/jlcr.3054","article-title":"Automated nucleophilic one-pot synthesis of 18F-L-DOPA with high specific activity using the GE TRACERlab MXFDG","volume":"56","author":"Martin","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","article-title":"Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET","volume":"64","author":"Morrish","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/jnnp.59.6.597","article-title":"Clinical and [18F] dopa PET findings in early Parkinson's disease","volume":"59","author":"Morrish","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0022-510X(85)90135-2","article-title":"Striatal dopamine distribution in parkinsonian patients during life","volume":"69","author":"Nahmias","year":"1985","journal-title":"J. Neurol. Sci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/brain\/aws358","article-title":"A progressive dopaminergic phenotype associated with neurotoxic conversion of \u03b1-synuclein in BAC-transgenic rats","volume":"136","author":"Nuber","year":"2013","journal-title":"Brain"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/mds.1139","article-title":"Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study","volume":"16","author":"Nurmi","year":"2001","journal-title":"Mov. Disord."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations","volume":"5","author":"Patlak","year":"1985","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.parkreldis.2015.08.015","article-title":"Phenotypic spectrum of \u03b1-synuclein mutations: new insights from patients and cellular models","volume":"22","author":"Petrucci","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/archneur.57.4.470","article-title":"Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F] fluorodopa positron emission tomographic study","volume":"57","author":"Rinne","year":"2000","journal-title":"Arch. Neurol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbrainres.2005.05.018","article-title":"Distribution kinetics of 18F-DOPA in weaver mutant mice","volume":"139","author":"Sharma","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brainresbull.2005.11.019","article-title":"Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson\u2019s disease and the neuroprotective role of coenzyme Q10","volume":"70","author":"Sharma","year":"2006","journal-title":"Brain Res. Bull."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/ana.410340304","article-title":"Human positron emission tomographic [18F] fluorodopa studies correlate with dopamine cell counts and levels","volume":"34","author":"Snow","year":"1993","journal-title":"Ann. Neurol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","article-title":"Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data","volume":"22","author":"Sossi","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/mds.23356","article-title":"Dopamine turnover increases in asymptomatic LRRK2 mutations carriers","volume":"25","author":"Sossi","year":"2010","journal-title":"Mov. Disord."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1471-4159.2009.05904.x","article-title":"Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study","volume":"109","author":"Sossi","year":"2009","journal-title":"J. Neurochem."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/00004647-200104000-00015","article-title":"A reversible tracer analysis approach to the study of effective dopamine turnover","volume":"21","author":"Sossi","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1471-4159.2012.07805.x","article-title":"Potential role of \u03b1-synuclein in neurodegeneration: studies in a rat animal model","volume":"122","author":"Stoica","year":"2012","journal-title":"J. Neurochem."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/2191-219X-3-69","article-title":"Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis","volume":"3","author":"Walker","year":"","journal-title":"EJNMMI Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/jcbfm.2012.120","article-title":"In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F] FDOPA PET","volume":"33","author":"Walker","year":"","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/jcbfm.1986.27","article-title":"Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands","volume":"6","author":"Wong","year":"1986","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/ncomms5240","article-title":"Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR\u2013Cas platform","volume":"5","author":"Yoshimi","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1095761\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T02:10:18Z","timestamp":1684894218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1095761\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":59,"alternative-id":["10.3389\/fnins.2023.1095761"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1095761","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fnins.2023.1095761.s001","asserted-by":"subject"}]},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"article-number":"1095761"}}